keyword
https://read.qxmd.com/read/38635894/three-year-follow-up-of-a-novel-orthopedic-ward-fracture-liaison-services-owfls-model
#1
JOURNAL ARTICLE
Xiongxiong Cai, Yijian Ying, Chi Zhang, Rong Xu, Baolin Xu, Dongdong Xia
OBJECTIVE: We established an orthopedic ward fracture liaison services (OWFLS) model and evaluated its role in improving detection rates of bone metabolic markers, treatment rates, and long-term treatability. METHODS: This observational retrospective cohort study included 120 patients aged >50 years hospitalized for primary osteoporotic fracture from January 2018 to January 2019 (group A: not included in OWFLS). Group B (included in OWFLS) comprised 120 patients from February 2019 to February 2020...
April 2024: Journal of International Medical Research
https://read.qxmd.com/read/38634483/bisphosphonate-alternative-regimens-for-the-prevention-of-osteoporotic-fragility-fractures-blast-off-a-mixed-methods-study
#2
JOURNAL ARTICLE
Opinder Sahota, Melanie Narayanasamy, Anastasios Bastounis, Zoe Paskins, Simon Bishop, Tessa Langley, Neil Gittoes, Sarah Davis, Ann Baily, Moira Holmes, Jo Leonardi-Bee
BACKGROUND: Bisphosphonates are a class of medication commonly used to treat osteoporosis. Alendronate is recommended as the first-line treatment; however, long-term adherence (both treatment compliance and persistence) is poor. Alternative bisphosphonates are available, which can be given intravenously and have been shown to improve long-term adherence. However, the most clinically effective and cost-effective alternative bisphosphonate regimen remains unclear. What is the most cost-effective bisphosphonate in clinical trials may not be the most cost-effective or acceptable to patients in everyday clinical practice...
April 2024: Health Technology Assessment: HTA
https://read.qxmd.com/read/38634210/differences-in-bone-turnover-markers-and-injury-risks-between-local-and-international-horses-a-victorian-spring-racing-carnival-study
#3
JOURNAL ARTICLE
Babatunde A Ayodele, Charles N Pagel, Eleanor J Mackie, Fiona Armour, Sean Yamada, Paul Zahra, Natalie Courtman, R Chris Whitton, Peta L Hitchens
BACKGROUND: Musculoskeletal injuries (MSI) are common in racehorses and have been of increasing concern in horses travelling internationally to compete. Understanding the differences in bone turnover between local horses and international horses following long-distance air transportation may inform MSI prevention strategies. OBJECTIVES: To understand the differences in bone turnover markers and risk of MSI between local horses and international horses following long-distance air transportation...
April 18, 2024: Equine Veterinary Journal
https://read.qxmd.com/read/38632835/prevalence-outcomes-and-complications-of-vitamin-d-deficiency-among-patients-with-multiple-myeloma-nationwide-burden-of-disease
#4
JOURNAL ARTICLE
Rahul Gujarathi, Manisha Rakesh Lakhanpal, Nikhila Chelikam, Divesh Manjani, Simmy Lahori, Sai Anusha Akella, Prashanth Gumpu Shivashankar, Francis Vino Dominic Savio, Abdirazak Ibrahim Ali, Navyatha Annareddy, Aryak Singh, Lokesh Manjani, Prasanthi Vanga, Avinash Adiga
Multiple myeloma (MM), constituting 10% of hematological malignancies, poses significant morbidity and mortality, especially with skeletal involvement. Bisphosphonate use in MM may lead to severe hypocalcemia due to vitamin D deficiency (VDD), exacerbating bone marrow plasma cell burden. We aimed to assess VDD prevalence and its impact on outcomes in MM patients. A retrospective cross-sectional analysis (2008-2018) of nationwide inpatient data identified adult MM hospitalizations with VDD using ICD-10-CM codes...
April 17, 2024: Journal of Investigative Medicine: the Official Publication of the American Federation for Clinical Research
https://read.qxmd.com/read/38631686/preoperative-prediction-for-periprosthetic-bone-loss-and-individual-evaluation-of-bisphosphonate-effect-after-total-hip-arthroplasty-using-artificial-intelligence
#5
JOURNAL ARTICLE
Akira Morita, Yuta Iida, Yutaka Inaba, Taro Tezuka, Naomi Kobayashi, Hyonmin Choe, Hiroyuki Ike, Eiryo Kawakami
AIMS: This study was designed to develop a model for predicting bone mineral density (BMD) loss of the femur after total hip arthroplasty (THA) using artificial intelligence (AI), and to identify factors that influence the prediction. Additionally, we virtually examined the efficacy of administration of bisphosphonate for cases with severe BMD loss based on the predictive model. METHODS: The study included 538 joints that underwent primary THA. The patients were divided into groups using unsupervised time series clustering for five-year BMD loss of Gruen zone 7 postoperatively, and a machine-learning model to predict the BMD loss was developed...
April 18, 2024: Bone & Joint Research
https://read.qxmd.com/read/38630878/prolonged-bone-health-benefits-for-breast-cancer-patients-following-adjuvant-bisphosphonate-therapy-the-bohfab-study
#6
JOURNAL ARTICLE
Janet Brown, Margaret A Paggiosi, Emma Rathbone, Walter Gregory, Gian Bertelli, Omar Din, Eugene McCloskey, David Dodwell, David Cameron, Richard Eastell, Robert Coleman
Adjuvant bisphosphonates are often recommended in postmenopausal women with early breast cancer at intermediate-to-high risk of disease recurrence, but the magnitude and duration of their effects on bone mineral density (BMD) and bone turnover markers (BTMs) are not well described. We evaluated the impact of adjuvant zoledronate on areal BMD and BTMs in a sub-group of patients who had completed the large 5-yr randomized Adjuvant Zoledronic Acid to Reduce Recurrence (AZURE) trial. About 224 women (recurrence free) who had completed the AZURE trial within the previous 3 mo were recruited from 20 UK AZURE trial sites...
March 4, 2024: Journal of Bone and Mineral Research
https://read.qxmd.com/read/38630464/impact-of-oral-bisphosphonate-drug-holiday-on-mortality-following-hip-fracture-a-population-based-cohort-study
#7
JOURNAL ARTICLE
Miriam T Y Leung, Justin P Turner, Clara Marquina, Jenni Ilomaki, Tim Tran, J Simon Bell
CONTEXT: Current clinical guidelines recommend a drug holiday after extended use of oral bisphosphonates. However, no studies have investigated the impact of drug holidays before hip fractures on post-fracture mortality. OBJECTIVE: To investigate the effect of drug holiday on post-fracture mortality in patients with extended use of oral bisphosphonates. DESIGN: Retrospective population-based cohort study. SETTING: All patients with hip fractures in Victoria, Australia from 2014-18...
April 17, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38626922/molecularly-imprinted-macroporous-hydrogel-promotes-bone-regeneration-via-osteogenic-induction-and-osteoclastic-inhibition
#8
JOURNAL ARTICLE
Jingxiao Chen, Yihan Jing, Yanhong Liu, Yongxi Luo, Yutong He, Xiaozhong Qiu, Qingbin Zhang, Huiyong Xu
Macroporous hydrogels offer physical supportive spaces and bio-instructive environment for the seeded cells, where cell-scaffold interactions directly influence cell fates and subsequently affect tissue regeneration post-implantation. Effectively modifying bioactive motifs at the inner pore surface provides appropriate niches for cell-scaffold interactions. A molecular imprinting method and sacrificial templates are introduced to prepare inner pore surface modification in the macroporous hydrogels. In detail, acrylated bisphosphonates (Ac-BPs) chelating to templates (CaCO3 particles) are anchored on the inner pore surface of the methacrylated gelatin-methacrylated hyaluronic acid-poly (ethylene glycol) diacrylate (GHP) macroporous hydrogel to form a functional hydrogel scaffold (GHP-int-BP)...
April 16, 2024: Advanced Healthcare Materials
https://read.qxmd.com/read/38626145/clodronate-disodium-does-not-produce-measurable-effects-on-bone-metabolism-in-an-exercising-juvenile-large-animal-model
#9
JOURNAL ARTICLE
Fernando B Vergara-Hernandez, Brian D Nielsen, John M Popovich, Char L Panek, Alyssa A Logan, Cara I Robison, Richard A Ehrhardt, Tyler N Johnson, Nicholas J Chargo, Thomas H Welsh, Amanda N Bradbery, Jessica L Leatherwood, Aimee C Colbath
Bisphosphonates are commonly used to treat and prevent bone loss, but their effects in active, juvenile populations are unknown. This study examined the effects of intramuscular clodronate disodium (CLO) on bone turnover, serum bone biomarkers (SBB), bone mineral density (BMD), bone microstructure, biomechanical testing (BT), and cartilage glycosaminoglycan content (GAG) over 165 days. Forty juvenile sheep (253 ± 6 days of age) were divided into four groups: Control (saline), T0 (0.6 mg/kg CLO on day 0), T84 (0...
2024: PloS One
https://read.qxmd.com/read/38625381/clinical-features-treatment-and-follow-up-of-oppg-and-high-bone-mass-disorders-lrp5-is-a-key-regulator-of-bone-mass
#10
JOURNAL ARTICLE
Na Ren, Shanshan Lv, Xiang Li, Chong Shao, Ziyuan Wang, Yazhao Mei, Wendi Yang, Wenzhen Fu, Yunqiu Hu, Ling Sha, Weiwei Hu, Zhenlin Zhang, Chun Wang
UNLABELLED: Osteoporosis-pseudoglioma syndrome (OPPG) and LRP5 high bone mass (LRP5-HBM) are two rare bone diseases with opposite clinical symptoms caused by loss-of-function and gain-of-function mutations in LRP5. Bisphosphonates are an effective treatment for OPPG patients. LRP5-HBM has a benign course, and age-related bone loss is found in one LRP5-HBM patient. PURPOSE: Low-density lipoprotein receptor-related protein 5 (LRP5) is involved in the canonical Wnt signaling pathway...
April 16, 2024: Osteoporosis International
https://read.qxmd.com/read/38622507/increased-risk-of-hypocalcemia-with-decreased-kidney-function-in-patients-prescribed-bisphosphonates-based-on-real-world-data-from-the-mid-net-%C3%A2-in-japan-a-new-user-cohort-study
#11
JOURNAL ARTICLE
Tomoaki Hasegawa, Maki Komamine, Chieko Ishiguro, Haruka Motomura, Kazuhiro Kajiyama, Takahiro Nonaka, Yuki Nakazato, Ryota Kimura, Harumi Maniwa, Toyotaka Iguchi, Naoya Horiuchi, Yoshiaki Uyama
BACKGROUND: In the post-marketing stage, cases of hypocalcemia associated with bisphosphonate preparations (BPs) have been reported in patients with decreased kidney function, despite warning against use of BPs in such patients in the package insert (PI) of Japan. The purpose of this study was to investigate the safety of BPs in patients with decreased kidney function. METHODS: The cohort study was conducted in patients with osteoporosis and newly prescribed bisphosphonate utilizing real-world data from MID-NET® in Japan...
April 15, 2024: BMC Nephrology
https://read.qxmd.com/read/38621662/the-preventive-effect-of-preoperative-and-postoperative-selenium-on-the-medication-related-osteonecrosis-of-the-jaw-an-animal-study-in-rats
#12
JOURNAL ARTICLE
Mustafa Isleyen, Muge Cina, Halil Asci, Ilter Ilhan, Ramazan Oguz Yuceer
BACKGROUND: Medication-related osteonecrosis of the jaw (MRONJ) is a condition that can occur primarily in patients undergoing or have previously undergone therapy with bisphosphonates, particularly in the presence of risk factors, such as tooth extraction (TE). PURPOSE: This study aimed to evaluate the effect of selenium (SEL) administration on the prevention of osteonecrosis of the jaw in an MRONJ animal model. STUDY DESIGN, SETTING, AND SAMPLE: This study was a longitudinal in vivo animal study using a TE model in a sample of 48 Wistar rats...
March 28, 2024: Journal of Oral and Maxillofacial Surgery
https://read.qxmd.com/read/38621345/conditioned-medium-of-human-mesenchymal-stem-cells-affects-stem-cell-senescence-in-osteoporosis
#13
JOURNAL ARTICLE
Kehong Liu, Kiyoshi Sakai, Junna Watanabe, Jiao Dong, Hiroshi Maruyama, Xinheng Li, Hideharu Hibi
Systemic transplantation of mesenchymal stem cells (MSCs) and conditioned medium derived from MSCs have been reported to recover bone loss in animal models of osteoporosis; however, the underlying mechanisms remain unclear. We recently reported that extracellular vesicles released from human mesenchymal stem cells (hMSCs) prevent senescence of stem cells in bisphosphonate-related osteonecrosis of the jaw model. In this study, we aimed to compare the effects of conditioned medium (hMSCs-CM) from early and late passage hMSCs on cellular senescence and to verify the benefits of CM from early passage hMSCs in mitigating the progression of osteoporosis through the prevention of cellular senescence...
April 1, 2024: Biochemical and Biophysical Research Communications
https://read.qxmd.com/read/38619605/the-cost-effectiveness-of-osteoporosis-medications-for-preventing-periprosthetic-fractures-following-femoral-neck-fracture-indicated-hip-arthroplasty-a-break-even-analysis
#14
JOURNAL ARTICLE
Amil R Agarwal, Matthew J Kinnard, Christopher Murdock, Amy Y Zhao, Uzoma Ahiarakwe, Jordan S Cohen, Kendall F Moseley, Gregory J Golladay, Savyasachi C Thakkar
UNLABELLED: Osteoporosis treatment following arthroplasty for femoral neck fracture (FNF) is associated with lower rates of periprosthetic fracture (PPF). Our study evaluated the economic viability of treatment in patients following arthroplasty and demonstrates that treatment with oral bisphosphonates can be cost-effective in preventing PPF. INTRODUCTION: Osteoporosis treatment following arthroplasty for femoral neck fracture (FNF) is associated with lower rates of periprosthetic fracture (PPF)...
April 15, 2024: Osteoporosis International
https://read.qxmd.com/read/38619297/evaluating-the-comparability-of-osteoporosis-treatments-using-propensity-score-and-negative-control-outcome-methods-in-uk-and-denmark-electronic-health-record-databases
#15
JOURNAL ARTICLE
Eng Hooi Tan, Trishna Rathod-Mistry, Victoria Y Strauss, James O'Kelly, Francesco Giorgianni, Richard Baxter, Vanessa C Brunetti, Alma Becic Pedersen, Vera Ehrenstein, Daniel Prieto-Alhambra
Evidence on the comparative effectiveness of osteoporosis treatments is heterogeneous. This may be attributed to different populations and clinical practice, but also to differing methodologies ensuring comparability of treatment groups before treatment effect estimation and the amount of residual confounding by indication. This study assessed the comparability of denosumab vs oral bisphosphonate (OBP) groups using propensity score (PS) methods and negative control outcome (NCO) analysis. A total of 280 288 women aged ≥50 years initiating denosumab or OBP in 2011-2018 were included from the UK Clinical Practice Research Datalink (CPRD) and the Danish National Registries (DNR)...
April 15, 2024: Journal of Bone and Mineral Research
https://read.qxmd.com/read/38619193/association-between-cdk4-6-inhibitors-and-drug-related-osteonecrosis-of-the-jaw-a-pharmacoepidemiological-study-using-the-fda-adverse-events-reporting-system
#16
JOURNAL ARTICLE
Makiko Go, Yoshihiro Noguchi, Rikuto Masuda, Hiroki Asano, Michio Kimura, Eiseki Usami, Tomoaki Yoshimura
The most common toxicities associated with cyclin-dependent kinase (CDK) 4/6 inhibitor therapy include decreased leukopenia and neutropenia due to the inhibition of CDK6 of leukocyte and neutrophil precursors in bone marrow. These hematological toxicities are more commonly observed with palbociclib administration than with abemaciclib administration, which is approximately 13 times more selective against CDK4 than CDK6. Thus, even though both successfully inhibit CDK4/6, the side effects of palbociclib and abemaciclib differ due to differences in selectivity...
April 15, 2024: International Journal of Cancer. Journal International du Cancer
https://read.qxmd.com/read/38615693/impact-of-osteoporosis-on-autogenous-bone-graft-resorption
#17
JOURNAL ARTICLE
Reza Tabrizi, Shervin Shafiei, Hamidreza Moslemi, Ramtin Dastgir, Zachary S Peacock
BACKGROUND: Osteoporosis is a common disorder that is characterized by decreased bone density and increased bone resorption. This bone resorption may affect the grafted bone during the maxillofacial reconstruction. PURPOSE: This study aimed to measure the association between osteoporosis and resorption of anterior iliac crest bone grafts used to reconstruct the atrophic anterior maxillae. STUDY DESIGN, SETTING, SAMPLE: This prospective cohort study included female patients requiring bone augmentation of the anterior maxilla...
March 27, 2024: Journal of Oral and Maxillofacial Surgery
https://read.qxmd.com/read/38614801/treatment-of-hypercalcaemia-of-malignancy-in-adults
#18
JOURNAL ARTICLE
Darran Mc Donald, Matthew T Drake, Rachel K Crowley
Hypercalcaemia of malignancy (HCM) is a common metabolic complication of advanced malignancies with a prevalence varying from 2-30%, depending on cancer type and disease stage. HCM is associated with impaired quality of life, increased risk of hospitalisation and limited survival. Evidence-based guidelines for management of HCM have been lacking to date, despite its prevalence and detrimental impact. This concise guidance highlights key recommendations from the recent Endocrine Society Clinical Practice Guidelines on Treatment of Hypercalcaemia of Malignancy in Adults, published in December 2022...
September 2023: Clinical Medicine: Journal of the Royal College of Physicians of London
https://read.qxmd.com/read/38614686/evaluation-of-patients-suitability-for-a-treatment-break-from-bisphosphonates
#19
JOURNAL ARTICLE
Annie Noor Gheasuddin
No abstract text is available yet for this article.
November 2023: Clinical Medicine: Journal of the Royal College of Physicians of London
https://read.qxmd.com/read/38614429/synergistic-effect-of-toll-like-receptor-2-ligands-and-alendronate-on-proinflammatory-cytokine-production-in-mouse-macrophage-like-raw-asc-cells-is-accompanied-by-upregulation-of-myd88-expression
#20
JOURNAL ARTICLE
Reiko Akaho, Yusuke Kiyoura, Riyoko Tamai
OBJECTIVES: Toll-like receptors (TLRs) recognize whole cells or components of microorganisms. Alendronate (ALN) is an anti-bone-resorptive drug that has inflammatory side effects. The aim in this study was to examine whether ALN augments TLR2 ligand-induced proinflammatory cytokine production using mouse macrophage-like RAW264.7 cells transfected with murine apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC) gene (hereafter, referred to as "RAW-ASC cells")...
April 11, 2024: Journal of Oral Biosciences
keyword
keyword
49305
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.